Patients with Medicare Advantage plans may have lower odds of receiving a kidney transplant referral than patients with ...

Initial CX-801 clinical data in advanced melanoma, both as monotherapy and in combination with KEYTRUDA, are expected by the end of 2026, with observed tolerability at doses surpassing the approved ...

Versus Q4 2025’s data-centric call, Q1 2026 added a more execution-and-capital framing, with Chris Ogden emphasizing “projected cash runway to at least the second half of 2028,” supporting a sustained ...

Findings suggest protein restriction doesn't have to be extreme ...

A 10% increase in ultraprocessed food intake was tied to lower attention scores and greater dementia risk in a ...

Chronic oral glucocorticoid use is linked to increased mortality, with risk rising alongside higher cumulative exposure and daily doses.

A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...

Predetermined Change Control Plans, Lifecycle Expectations, and New Transparency Obligations - The FDA has been steadily laying ...

Maternal abuse history significantly increases the risk for social-emotional delay in children at age 3 years.

Jazz announced U.S. FDA acceptance with Priority Review of Supplemental Biologics License Application (sBLA) for zanidatamab in first-line ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...